Dissemination and implementation of DIGEST™ as an evidence-based measurement tool for dysphagia in cancer

传播和实施 DIGEST™ 作为癌症吞咽困难的循证测量工具

基本信息

项目摘要

ABSTRACT Dysphagia (difficulty swallowing) is a highly prevalent and impactful condition with significant burden on the healthcare system. Across the lifespan, dysphagia is associated with excess risk of mortality, increased length of stay, aspiration pneumonia, and malnutrition thereby elevating medical costs and resource utilization. Not only a health problem, dysphagia also adversely affects quality of life and daily function with disproportionate impact on cancer survivors. Adoption of evidence-based methods into clinical practice lags decades behind discovery. One such gap is adoption of evidence-based practices (EBP) by speech-language pathologists in dysphagia management. Evidence-based dysphagia care begins with evidence-based swallowing evaluation. Significant progress has been made in the field of dysphagia to develop evidence-based evaluation methods, with particular emphasis on physiologic characterization of swallowing. The relative safety and efficiency of swallowing, that is how well a food or liquid bolus is kept out of the airway and clears fully through the pharynx into the esophagus, is a fundamental driver of clinical decision making – yet, remains inconsistently assessed and reported in clinical practice. To address this gap, the investigators’ developed DIGEST™ (Dynamic Imaging Grade of Swallowing Toxicity). DIGEST is an EBP tool to grade the severity of pharyngeal dysphagia based on results of a radiographic (videofluoroscopic) modified barium swallow (MBS) study. DIGEST uses a basic flowsheet and rubric (available open access via PMC) to summarize the patterns of penetration/aspiration and pharyngeal residue observed on the MBS as markers of swallowing safety and efficiency. DIGEST is a pragmatic yet robust measure validated in the head and neck cancer population, and adopted into routine practice at the PI’s institution with over 11,000 MBS graded in the clinic using the methodology since development in 2016. Peer-reviewed research shows adoption of DIGEST in external academic medical settings and federally funded clinical trials. Despite this promise, several obstacles still limit widespread adoption in routine cancer care. These include scalability to fit diverse clinical contexts outside the PI’s environment and uncertainty about best implementation strategies. The long-term goal of this project is to improve dysphagia care and patient outcomes through reliable adoption of DIGEST into routine clinical practice. Our central hypothesis is that DIGEST scales-up maintaining validity in diverse cancer populations under common clinical practice variations with reliable adoption facilitated by an active implementation strategy. The objective of this application is to use dissemination and implementation (D&I) science to accomplish the following Specific Aims: 1) demonstrate validity of DIGEST in diverse oncology populations and imaging acquisition protocols, 2) examine context and fidelity of natural dissemination of DIGEST in real-world, early adopters, and 3) evaluate active implementation strategies to improve reach and fidelity of DIGEST in clinical practice. With dense multi-site networks and content expertise, the investigators are uniquely equipped to conduct the proposed D&I project. We expect this work to improve care by narrowing the research-to-practice gap in dysphagia diagnostics.
抽象的 吞咽困难(吞咽困难)是一种高度普遍且有影响力的状况,对 医疗保健系统。在整个寿命中,吞咽困难与死亡率过多,长度增加有关 住院,吸气性肺炎和营养不良,从而提高医疗成本和资源利用率。不仅 一个健康问题,吞咽困难还会不利地影响生活质量和日常功能,影响不成比例 关于癌症存活。将基于证据的方法采用临床实践落后于发现的数十年。 这样的差距之一是吞咽困难中语言病理学家改编基于证据的实践(EBP) 管理。基于证据的吞咽困难始于基于证据的吞咽评估。重要的 在吞咽困难领域取得了进展,以开发基于证据的评估方法 强调吞咽的物理表征。吞咽的相对安全性和效率,即 食物或液体推注的含量如何,并通过咽部完全清除食管, 是临床决策的基本驱动力 - 然而,在临床上仍然不一致地评估和报告 实践。为了解决这一差距,调查人员的开发了Digest™(吞咽的动态成像等级 毒性)。 Digest是根据A的结果对咽吞咽困难进行评分的EBP工具 射线照相(视频荧光镜)修饰的钡燕子(MBS)研究。 Digest使用基本的流程图和 标题(可通过PMC开放访问)来总结穿透/抽吸的模式和咽 在MBS上观察到的残留物是吞咽安全性和效率的标记。摘要是一种务实而强大的 在头部和颈部癌的人群中验证的措施,并在PI机构中采用常规实践 自2016年开发以来,使用该方法在诊所中分级超过11,000 MB。 研究表明,在外部学术医疗环境和联邦资助的临床试验中采用了摘要。 尽管有希望,但几个障碍仍然限制了常规癌症护理中的宽度采用。这些包括 适合潜水员临床环境以外的潜水员的可伸缩性以及最佳实施的不确定性 策略。该项目的长期目标是通过可靠的 将摘要采用到常规临床实践中。我们的中心假设是消化缩放维护 在常见的临床实践变化下采用可靠的采用量 通过积极的实施策略。本应用的目的是使用传播和 实施(D&I)科学以实现以下具体目的:1)在 潜水肿瘤学人群和成像采集方案,2)检查环境和自然的保真度 在现实世界,早期采用者和3)评估主动实施策略中传播摘要 在临床实践中提高覆盖范围和消化性。具有密集的多站点网络和内容专业知识, 调查人员在执行拟议的D&I项目方面非常等同于。我们希望这项工作能改善 通过缩小吞咽困难诊断的研究对实践差距来护理。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Katherine Arnold Hutcheson其他文献

Katherine Arnold Hutcheson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Katherine Arnold Hutcheson', 18)}}的其他基金

Hypoglossal neuropathy in the pathogenesis of radiation associated dysphagia (hRAD)
放射相关吞咽困难 (hRAD) 发病机制中的舌下神经病变
  • 批准号:
    10645692
  • 财政年份:
    2023
  • 资助金额:
    $ 69.88万
  • 项目类别:
Lingual Strength & Dysphagia after Oropharynx Cancer: Proton vs. Photon Radiation
语言力量
  • 批准号:
    9103047
  • 财政年份:
    2015
  • 资助金额:
    $ 69.88万
  • 项目类别:
Lingual Strength & Dysphagia after Oropharynx Cancer: Proton vs. Photon Radiation
语言力量
  • 批准号:
    8959426
  • 财政年份:
    2015
  • 资助金额:
    $ 69.88万
  • 项目类别:

相似国自然基金

采用新型视觉-电刺激配对范式长期、特异性改变成年期动物视觉系统功能可塑性
  • 批准号:
    32371047
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
破解老年人数字鸿沟:老年人采用数字技术的决策过程、客观障碍和应对策略
  • 批准号:
    72303205
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
通过抑制流体运动和采用双能谱方法来改进烧蚀速率测量的研究
  • 批准号:
    12305261
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
采用多种稀疏自注意力机制的Transformer隧道衬砌裂缝检测方法研究
  • 批准号:
    62301339
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
政策激励、信息传递与农户屋顶光伏技术采用提升机制研究
  • 批准号:
    72304103
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Implementation of Innovative Treatment for Moral Injury Syndrome: A Hybrid Type 2 Study
道德伤害综合症创新治疗的实施:2 型混合研究
  • 批准号:
    10752930
  • 财政年份:
    2024
  • 资助金额:
    $ 69.88万
  • 项目类别:
Optimization of electromechanical monitoring of engineered heart tissues
工程心脏组织机电监测的优化
  • 批准号:
    10673513
  • 财政年份:
    2023
  • 资助金额:
    $ 69.88万
  • 项目类别:
The University of Miami AIDS Research Center on Mental Health and HIV/AIDS - Center for HIV & Research in Mental Health (CHARM)Research Core - EIS
迈阿密大学艾滋病心理健康和艾滋病毒/艾滋病研究中心 - Center for HIV
  • 批准号:
    10686546
  • 财政年份:
    2023
  • 资助金额:
    $ 69.88万
  • 项目类别:
The RaDIANT Health Systems Intervention for Equity in Kidney Transplantation
Radiant 卫生系统干预肾移植的公平性
  • 批准号:
    10681998
  • 财政年份:
    2023
  • 资助金额:
    $ 69.88万
  • 项目类别:
Extensible Open Source Zero-Footprint Web Viewer for Cancer Imaging Research
用于癌症成像研究的可扩展开源零足迹 Web 查看器
  • 批准号:
    10644112
  • 财政年份:
    2023
  • 资助金额:
    $ 69.88万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了